PI
BIIB icon

PEAK6 Investments’s Biogen BIIB Stock Holding History

PEAK6 Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.98M Sell
10,200
-11,100
-52% -$2.32M ﹤0.01% 1519
2024
Q2 		$4.94M Sell
21,300
-65,900
-76% -$14.3M 0.01% 850
2024
Q1 		$18.8M Buy
87,200
+2,500
+3% +$586K 0.05% 303
2023
Q4 		$21.9M Buy
84,700
+3,500
+4% +$860K 0.08% 230
2023
Q3 		$20.9M Sell
81,200
-59,300
-42% -$15.9M 0.1% 174
2023
Q2 		$40M Sell
140,500
-76,100
-35% -$22.7M 0.18% 79
2023
Q1 		$60.2M Sell
216,600
-287,100
-57% -$79.4M 0.29% 45
2022
Q4 		$139M Buy
503,700
+326,900
+185% +$92.3M 0.81% 8
2022
Q3 		$47.2M Sell
176,800
-68,900
-28% -$14.6M 0.2% 73
2022
Q2 		$61.5M Buy
245,700
+83,500
+51% +$17.1M 0.12% 130
2022
Q1 		$34.2M Sell
162,200
-99,900
-38% -$21.7M 0.07% 240
2021
Q4 		$62.9M Buy
262,100
+237,800
+979% +$61.1M 0.13% 139
2021
Q3 		$6.88M Sell
24,300
-70,500
-74% -$23.1M 0.02% 946
2021
Q2 		$32.8M Sell
94,800
-158,800
-63% -$48.1M 0.08% 233
2021
Q1 		$70.9M Sell
253,600
-163,200
-39% -$44M 0.17% 97
2020
Q4 		$102M Buy
416,800
+18,500
+5% +$4.77M 0.21% 74
2020
Q3 		$113M Buy
398,300
+216,300
+119% +$60.3M 0.28% 56
2020
Q2 		$48.7M Sell
182,000
-72,000
-28% -$21.6M 0.17% 118
2020
Q1 		$80.4M Buy
254,000
+73,800
+41% +$22.4M 0.47% 34
2019
Q4 		$53.5M Buy
180,200
+104,300
+137% +$28.9M 0.28% 61
2019
Q3 		$17.7M Buy
75,900
+25,900
+52% +$6.03M 0.11% 185
2019
Q2 		$11.7M Buy
50,000
+28,600
+134% +$6.6M 0.08% 305
2019
Q1 		$5.06M Sell
21,400
-5,200
-20% -$1.64M 0.03% 702
2018
Q4 		$8M Sell
26,600
-137,800
-84% -$44M 0.05% 416
2018
Q3 		$58.1M Buy
+164,400
New +$56.6M 0.25% 52

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PEAK6 Investments's BIIB Position: Q2 2024 in Review

PEAK6 Investments sold out of Biogen (BIIB) in Q2 2024, closing a stake of 14,416 shares — an estimated $3.13M sold.

PEAK6 Investments first reported a position in BIIB in Q4 2018 and held it in 22 quarters. The position peaked at $50.1M in Q2 2021. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • PEAK6 Investments reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 14,416 Biogen shares in Q2 2024, an estimated $3.13M.
  • PEAK6 Investments first reported a position in Biogen in Q4 2018 and held it in 22 quarters.
  • PEAK6 Investments's Biogen position peaked at $50.1M in Q2 2021.
  • 943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.